Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 49 minutes agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 1 day agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 4 hours agoOfficials noted that COVID-19 is rapidly evolving. The goal of the group was to capture the virus’...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 5 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 2 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 5 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
Why Is Novavax (NVAX) Stock Up 20% Today?
InvestorPlace· 2 hours agoNovavax (NASDAQ:NVAX) is on a recovery trek after collapsing in late 2021. Regarding timeline, the latter two firms said that they would be able to...
F.D.A. Advisers Recommend a New Covid Vaccine Formula for the Fall
New York Times· 3 hours agoA committee of advisers to the Food and Drug Administration voted on Wednesday to update the formula...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 2 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 1 day agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...